injection of tumour necrosis factor (TNF) in animals causes severe liver ce
ll toxicity, especially when D-(+)-galactosamine (GalN) is co-administered,
After challenge with TNF/GalN, serum complement activity (CH50 and APCH50)
decreased dramatically, suggesting strong activation of both the classical
and the alternative pathways. TNF or GalN alone had no such effect. A clea
vage product of complement protein C3 [C3(b)] was deposited on the surface
of hepatocytes of TNF/GalN-treated mice, Intravenous administration of cobr
a venom factor (CVF), which depletes complement, inhibited the development
of hepatitis, However, CVF pretreatment also protected C3-deficient mice. P
retreatment of mice with a C1q-depleting antibody did not prevent TNF/GalN
lethality, although the anti-C1q antibody had depleted plasma C1q, Factor B
-deficient and C3-deficient mice, generated by gene targeting, proved to be
as sensitive to TNF/GalN as control mice. Furthermore, induction of lethal
shock by platelet-activating factor, an important mediator in TNF-induced
hepatic failure, was not reduced in C3-deficient mice, These data indicate
that complement, although activated, plays no major role in the generation
of acute lethal hepatic failure in this model and that CVF-induced protecti
on is independent of complement depletion. (C) 1999 Academic Press.